CDK10 has been identified as a candidate tumor suppressor in hepatobiliary cancers, including hepatocellular carcinoma (HCC) and biliary tract cancers (BTC) (31, 32, 64, 67). This evidence concerns the gene CDK10 and hepatocellular carcinoma.